Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651333 · ClinicalTrials.gov registry record
fMRI and Opioid Abstinence
A clinical trial of Opioid Use and Opioid-Related Disorders, sponsored by Yale University.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06651333 is a study of Opioid Use and Opioid-Related Disorders that is actively recruiting participants, run by Yale University. The registered enrollment target is 240 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06651333, a study of Opioid Use and Opioid-Related Disorders, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST fMRI
Study Locations (1)
Connecticut
- The APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2029-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06651333
The ClinicalTrials.gov registry entry for NCT06651333 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which fMRI is the first listed.
NCT06651333 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06651333 about?
NCT06651333 is a clinical study titled "fMRI and Opioid Abstinence". This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
What is the current status of trial NCT06651333?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2024-12-12. Estimated completion is 2029-11.
What conditions does trial NCT06651333 study?
This clinical trial studies the following conditions: Opioid Use, Opioid-Related Disorders, Opioid Dependence, Opioid Abuse, Drug Use Disorder.
What interventions are being tested in trial NCT06651333?
The interventions under investigation include: fMRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06651333?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651333 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.